Dyne Therapeutics, Inc.
DYN
$12.40
$0.161.31%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 642.27M | 723.67M | 778.84M | 453.55M | 123.10M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 17.01M | 12.72M | 13.48M | 34.59M | 6.28M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 659.28M | 736.39M | 792.32M | 488.14M | 129.38M |
|
|
|||||
| Total Current Assets | 659.28M | 736.39M | 792.32M | 488.14M | 129.38M |
| Net Property, Plant & Equipment | 30.01M | 30.52M | 31.64M | 32.22M | 33.39M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.94M | 1.94M | 1.93M | 1.92M | 2.32M |
| Total Assets | 691.23M | 768.84M | 825.88M | 522.28M | 165.08M |
|
|
|||||
| Total Accounts Payable | 6.56M | 6.16M | 1.89M | 7.21M | 22.94M |
| Total Accrued Expenses | 30.85M | 32.29M | 23.09M | 10.39M | 23.44M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.85M | 4.81M | 4.78M | 4.76M | 4.72M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 42.26M | 43.26M | 29.75M | 22.36M | 51.10M |
|
|
|||||
| Total Current Liabilities | 42.26M | 43.26M | 29.75M | 22.36M | 51.10M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 19.14M | 20.04M | 20.94M | 21.86M | 22.70M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 61.40M | 63.30M | 50.69M | 44.22M | 73.79M |
|
|
|||||
| Common Stock & APIC | 1.58B | 1.57B | 1.54B | 1.18B | 723.80M |
| Retained Earnings | -949.93M | -860.39M | -763.26M | -698.16M | -632.51M |
| Treasury Stock & Other | 6.00K | 478.00K | -240.00K | -132.00K | -- |
| Total Common Equity | 629.84M | 705.54M | 775.19M | 478.06M | 91.29M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 629.84M | 705.54M | 775.19M | 478.06M | 91.29M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 629.84M | 705.54M | 775.19M | 478.06M | 91.29M |
|
|
|||||
